Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This project aims to develop a smart communication system for patients with amyotrophic lateral sclerosis (ALS), especially for stage 3 and stage 4 (late stage). Patients with ALS will be able to communicate with outer environment by means of mental control or eye tracking control, which would increase their life quality. This integrated research project includes experts from different domains and proposes a solution for smart communication system.
A multi-function brain- computer interface (BCI) communication system will be developed by combining a BCI system (subproject 1) and a 3D electro-cap (subproject 3). Then, this system and an eye-controlled device (subject 2) are further integrated to a smart communication system. The outputs of the system are presented with the original voice the ALS patients, which will be achieved by using the voice reconstruction technology (subproject 4) in this project. All the user-interfaces of the BCI and eye tracking systems will be re-deigned by employing human factors engineering to increase the usability of the proposed smart communication system for ALS. Finally, the validity of the system in improving the life quality of ALS will be assessed through clinical study.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| traditional communication system | Active Comparator |
| |
| intelligent communication system | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| communication system | Other | We will use the questionnaire "Amyotrophic Lateral Sclerosis Supportive Care Needs ,Amyotrophic Lateral Sclerosis Specific Quality of Life Instrument-Revised, Beck Depression Inventory and Caregiver Burden Scale. |
| Measure | Description | Time Frame |
|---|---|---|
| Part 1- Amyotrophic Lateral Sclerosis Supportive Care Needs | To comprehensively assess the perceived supportive care needs of patients with ALS. | 30mins |
| Part 2 - Amyotrophic Lateral Sclerosis Specific Quality of Life Instrument-Revisedclinical study | We try to understand the validity of the system. This measurement can help us know that our system could be beneficial or not on the quality of life in patient with ALS. | one week |
| Measure | Description | Time Frame |
|---|---|---|
| Part 2 - Beck Depression Inventoryc | We try to understand the validity of the system. This measurement can help us know that our system could be beneficial or not on the degree of depression of life in patient with ALS. | one week |
| Caregiver Burden Scale |
Not provided
Part one:
Inclusion Criteria:
ALS diagnostic criteria (Brooks et al., 2000).Must have the following characteristics:
Also, there are no features:
Electrophysiological or pathological evidence of other diseases that may explain signs of LMN and/or UMN degradation
Neuroimaging evidence of other diseases that may explain the observed clinical electrophysiological signs.
Exclusion Criteria:
Part two:
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Cheng Liang Chou | Contact | +8862-28757296 | cl_chou@vghtpe.gov.tw | |
| SI-HUEI LEE | Contact | +886938591985 | leesihuei@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cancer Center, Taipei Veterans General Hospital | Recruiting | Taipei | 11217 | Taiwan |
Not provided
| ID | Term |
|---|---|
| D000690 | Amyotrophic Lateral Sclerosis |
| ID | Term |
|---|---|
| D013118 | Spinal Cord Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D016472 | Motor Neuron Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We try to understand the validity of the system. This measurement can help us know that our system could be beneficial or not on the burden in patient's caregiver. |
| one week |
| D019636 | Neurodegenerative Diseases |
| D057177 | TDP-43 Proteinopathies |
| D009468 | Neuromuscular Diseases |
| D057165 | Proteostasis Deficiencies |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |